Aastrom Biosciences, Inc.

Aastrom Biosciences, Inc., which is categorized as a micro cap company in the healthcare sector, has received an Investor Awareness Index score of 4.8 out of a possible 10.

How does Aastrom Biosciences, Inc. compare?

This proprietary report shows some of the investor awareness initiatives the Investor Awareness Index considers that positively impacted Aastrom Biosciences, Inc.' s score:

• Amount of Sell-Side Analyst Coverage

• Amount of Media Coverage

• Employment of an Investor Relations Officer or Outside Agency Whose Responsibility is to Interact with the Investment Community

For a more comprehensive list of criteria used in our ratings, please go to Investor Awareness Index Scoring

This report is for informational purposes only. Visit About the Investor Awareness Index for more information.

Aastrom Biosciences, Inc. Headlines

• Aastrom to Present at 12th Annual Rodman & Renshaw Global Investment Conference
• AASTROM BIOSCIENCES INC Files SEC form 10-K, Annual Report
• AASTROM BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendment or Waiver to Code of
• Stem-cell stocks regain ground
• Stem Cell Companies Immune to Federal Ruling